Granted Patent
B2
US 7,268,223 · App. 09/919,162 · Granted Sep 11, 2007
Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof
Assignee:
Wyeth
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The invention relates to soluble proteins which bind to the molecule known as IL-TIF/IL-22. The proteins can antagonize the effect of IL-TIF/IL-22 on target cells. The nucleic acid molecules encoding the proteins, and uses of the protein, are also described.
Claims (2)
1. An isolated nucleic acid molecule which encodes a soluble protein which binds to IL-TIF/IL-22 comprising the nucleotide aequence of SEQ ID NO: 5.
2. An isolated nucLeic acid molecule which encodes a soluble protein which binds to IL-TIF/IL-22, consisting of the nucleotide sequence set forth at SEQ ID NO: 5.
Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Feb 12, 2007
From: LUDWIG INSTITUTE FOR CANCER RESEARCH
To: WYETH
Reel/Frame 018907/0819 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Oct 9, 2001
From: RENAULD, JEAN-CHRISTOPHE; DUMOUTIER, LAURE
To: LUDWIG INSTITUTE FOR CANCER RESEARCH
Reel/Frame 012242/0408 →
Continuity (3)
Provisional Application
6024549500
· Nov 3, 2000
Provisional Application
6023458300
· Sep 22, 2000